Three FTSE Stock Under Focus – Gateley (Holdings) Plc, Mi-Pay Group Plc And Allergy Therapeutics Plc

  • Oct 23, 2019 BST
  • Team Kalkine
Three FTSE Stock Under Focus – Gateley (Holdings) Plc, Mi-Pay Group Plc And Allergy Therapeutics Plc

Gateley (Holdings) Plc

Gateley (Holdings) Plc (GTLY) is a Birmingham, the United Kingdom based legal holding company whose subsidiary companies are engaged in the provision of commercial legal and professional services. These companies provide a wide variety of services which include the areas like Banking and Finance, Corporate, Pensions, Private Clients, Commercial, Dispute Resolution, People and Rewards, Real Estate, Regulatory and other Arbitration service. The company provides its services to business owners and Managers, Lenders and Borrowers, Company secretaries, Pension trustees, families, Private equity firms, Housebuilders, real estate investors and developers, HR Professionals Recruitment business, and across various other individuals and industries. The company’s range of services includes solutions like Buying, selling and managing property assets, preventing and solving family disputes, corporate deal-making, protecting clients’ business and managing and mitigating all kinds of risks associated, Developing clients’ people and their organisation, Resolving a dispute, documenting debt and securities, setting up or starting out a business in the United Kingdom as well as governing and guiding he business on various aspects, especially Legal and compliance.

GTLY Financial Performance (Preliminary results for the year ended 30th April 2019)

On 16th July 2019, the company made a press release regarding its preliminary results for the year ended 30th April 2019. In the press release, the company highlighted that the revenue increased by 20 per cent year on year from £86.1 million in FY 2018 to £103.5 million in FY 2019. The company reported that the revenue was driven by core legal services which increased by 9.5 per cent year on year and the revenue grew 10.7 per cent through acquisitions. The company also reported a year on year increase of 15.7 per cent in the Adjusted Earnings before Interest Taxes Depreciation and Amortization (EBITDA) from £16.5 million in FY 2018 to £19.1 million in FY 2019. Profit before Tax (PBT) was reported at £15.1 million in FY 2019, an 8.9 per cent increase from FY 2018’s Profit Before tax at £14.6 million. Profit After Tax (PAT) was up from £11.8 million in FY 2018 to £13.0 million in FY 2019, an increase of 10.6 per cent year on year. Basic Earnings per share (EPS) was reported at GBX 11.83 per share in FY 2019, a 7.3 per cent year on year increase as compared to the Basic Earnings per share reported in FY 2018 at GBX 11.03 per share. Net assets were reported at £30.6 million and Net Debt at £3.2 million as on 30th April 2019. The board proposed a final dividend for the year at GBX 5.4 per share, which took the total dividend for the year to GBX 8.0 per share, as compared to the total dividend in FY 2018 at GBX 7.0 per share, an increase of 14.3 per cent year on year, as a reflection of the board’s progressive dividend policy.

GTLY Share Performance

On 23rd October 2019, at 08:06 AM GMT, while writing, Gateley (Holdings) stock traded at GBX 162.50 per share, an increase of 0.62 per cent or GBX 1.00 per share in comparison with the previous day’s closing price which was reported at GBX 161.50 per share. While writing, the company’s stock traded 37.24 per cent above its 52-week low price of GBX 118.4 per share, set on December 28, 2018. At the current market price, the company’s stock was trading 8.45 per cent below its 52-week high price of GBX 177.50 per share, which the company’s stock hit on February 07, 2019. The company’s Market Capitalisation was around GBP 183.63 million.

By the time of writing, 8,910 stocks of the company had been traded for the day. The average volume of trading per day for last one year has been 429,950. The stock has gained 12.85 per cent in the last one year from the price of GBX 143.75 per share.

The Beta of the stock has been reported to be at 0.9765, from which it can be inferred that the stock’s price movement, is less volatile as compared to the movement of the comparative benchmark index.

 

Mi-Pay Group Plc

Mi-Pay Group Plc (MPAY) is a London based digital payments company that provides secured digital payment services, that assess, manage and mitigate fraud risks, which means very secured transactions for the customers. The company’s USPs include high payment success rates of 90 per cent, which is higher than that of the industry at 80 per cent, more traffic of consumers than E-commerce websites, and an extremely low bounce rate of 8 per cent compared to an industry average of 30 per cent. The company’s strategy for growth is to provide a Risk-free, Friction-Less and No-Limit payment model to customers. Other than the transactions segment mentioned above, which is the core business of the company, the company also has a professional services segment through which the company develops, delivers and hosts all the platforms on which the services and solutions are rendered.

MPAY Financial Performance

On 25th September 2019, Mi-Pay made a press release reporting the interim results for half-year ended 30th June 2019. The company announced that in the reporting period, they renewed contracts with two major clients, which delivered a combined 43 per cent of the total annual revenue in the year 2018. The company reported fully managed payments at £58.1 million in H1 2019, which was a 15 per cent increase from H1 2018 at £50.2 million. The company reportedly recognised revenue of £1.7 million in the first half of 2019 as compared to revenue of £1.6 million in the first half of the previous year. The company reported the administrative expenses at £1.1 million, which was the same as the previous year. This was due to the cost reduction strategy that began in the year 2018. There was also a decrease in the loss per share from approximately £300,000 in H1 2018 to £approximately £200,000 in H1 2019. The company reported a cash balance of £3.1 million as on 30th June 2019.

MPAY Share Performance

On 23rd October 2019, at 08:43 AM GMT, while writing, MPAY stock traded at GBX 7.50 per share, no change in comparison with the previous day’s closing price. While writing, Mi-Pay Group Plc traded 25.00 per cent above its 52-week low price of GBX 6.00, set on October 14, 2019. The company’s Market Capitalisation was around GBP 3.43 million.

The average volume of trading per day for last one year has been 35,210. The stock has lost 25 per cent in the last one year from the price of GBX 10.25 per share.

The Beta of the stocks has been reported to be at 0.5949, from which it can be inferred that the stock’s price movement, is less volatile as compared to the movement of the comparative benchmark index.

 

Allergy Therapeutics Plc

Allergy Therapeutics Plc (AGY) is a pharmaceuticals company that is engaged in the immunology business with market-leading aluminium free products for allergy treatments. The company has injectable as well as oral formats of Specific Immunotherapy products available and a range of 80 specialist diagnostic products. The company has operations in countries like Austria, Germany, Italy, Netherlands, Switzerland and Spain, as well as the United Kingdom. The company is also running two highly Research and development programmes which include the Phase I, II and III Clinical Development Program in the European Union as well as a Development Program in the United States Market.

AGY Financial Performance

On 25th September 2019, the company made a press release in which it announced its full-year results for the year ended 30th June 2019. The company reported an 8 per cent year on year increase in the revenue to £73.7 million in 2019 as compared to £68.3 million in 2018. Operations across all European countries except Italy showed good sales growth, with the Netherlands performing the best with the highest growth at 16 per cent year on year. The company also reported a 22 per cent year on year increase in the Pre R&D operating Profit at £11.3 million in 2019 as compared to the Pre-R&D profit at £9.3 million in 2018. Although the cost of sales increased, the company also reported an increase in Gross Profit to £55.3 million in 2019 as compared to £51.3 million in 2018. The company reported the profit for the year at £3.46 million in 2019, as compared to a loss of £7.5 million in 2018. This was the biggest indicator of company’s excellent performance in FY19. The company reported a Cash Balance of £27.4 million and a combined debt of £2.43 million as on 30th June 2019.

AGY Share Performance

On 23rd October 2019, at 08:56 AM GMT, while writing, AGY stock traded at GBX 11.80 per share; an increase of 0.43 per cent or GBX 0.05 per share as compared to the previous day’s closing price at GBX 11.75 per share. While writing, Allergy Therapeutics Plc traded 61.64 per cent above its 52-week low price of GBX 7.30, set on March 19, 2019. The company’s Market Capitalisation was around GBP 74.75 million.

By the time of writing, 33,940 of company’s stocks had been traded for the day. The average volume of trade, per day, in the last one year was at 75,930 stocks. The company’s stock has lost 33.52 per cent in the last one year, from the price of GBX 18.00 per share.

The Beta of the stock has been reported to be at 0.8832, from which it can be inferred that the stock’s price movement, is less volatile as compared to the movement of the comparative benchmark index.

With Bank of England reducing the interest rates to a historic low level, the spotlight is back on diverse investment opportunities. 

Amidst this, are you getting worried about these falling interest rates and wondering where to put your money?

Well! Team Kalkine has a solution for you. You still can earn a relatively stable income by putting money in the dividend-paying stocks.

We think it is the perfect time when you should start accumulating selective dividend stocks to beat the low-interest rates, while we provide a tailored offering in view of valuable stock opportunities and any dividend cut backs to be considered amid scenarios including a prolonged market meltdown.

To know more about these dividend stocks, click here

CLICK HERE FOR YOUR FREE REPORT!
   
x
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK